e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of obstructive sleep apnea syndrome on superoxide dysmutase-1 activity in erythrocytes of high risk for type 2 diabetes (pre-diabetic) males
S. Cofta, E. Wysocka, T. Piorunek, M. Rzymkowska, L. Torlinski, H. Batura-Gabryel (Poznan, Poland)
Source:
Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Session:
Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Session type:
Oral Presentation
Number:
1427
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Cofta, E. Wysocka, T. Piorunek, M. Rzymkowska, L. Torlinski, H. Batura-Gabryel (Poznan, Poland). The impact of obstructive sleep apnea syndrome on superoxide dysmutase-1 activity in erythrocytes of high risk for type 2 diabetes (pre-diabetic) males. Eur Respir J 2011; 38: Suppl. 55, 1427
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence
Source: Sleep and Breathing Conference 2021
Year: 2021
The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011
Prevalence of obstructive sleep apnoea in men with type 2 diabetes
Source: Eur Respir J 2005; 26: Suppl. 49, 567s
Year: 2005
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
High prevalence of obstructive sleep apnea syndrome in a type 1 diabetic adult population: A pilot study
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001
Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Relationship between age and cardiovascular diseases (CVD) in obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008
Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults?
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003
Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012
Severe sleep apnea, type 2 diabetes and beneficial effects of CPAP on nocturnal glucose control
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008
Cystatin C as a marker of cardiovascular diseases in patients with obstructive sleep apnea (OSA) with concomitant diabetes mellitus type 2 (DM2)
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 113s
Year: 2004
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Obstructive sleep apnoea syndrome (OSAS) and diabetes: influence of obesity
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome
Source: Eur Respir J 2003; 22: 156-160
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept